These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 2201072

  • 1. Zidovudine resistance of human immunodeficiency virus.
    Richman DD.
    Rev Infect Dis; 1990; 12 Suppl 5():S507-10; discussion S510-2. PubMed ID: 2201072
    [Abstract] [Full Text] [Related]

  • 2. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.
    Larder BA, Darby G, Richman DD.
    Science; 1989 Mar 31; 243(4899):1731-4. PubMed ID: 2467383
    [Abstract] [Full Text] [Related]

  • 3. Susceptibility to nucleoside analogues of zidovudine-resistant isolates of human immunodeficiency virus.
    Richman DD.
    Am J Med; 1990 May 21; 88(5B):8S-10S. PubMed ID: 2186629
    [Abstract] [Full Text] [Related]

  • 4. Incidence of zidovudine-resistant human immunodeficiency virus isolated from patients before, during, and after therapy.
    Land S, McGavin C, Lucas R, Birch C.
    J Infect Dis; 1992 Nov 21; 166(5):1139-42. PubMed ID: 1402026
    [Abstract] [Full Text] [Related]

  • 5. AZT resistance in isolates of HIV.
    Richman DD.
    Immunodefic Rev; 1991 Nov 21; 2(4):315-8. PubMed ID: 2059436
    [Abstract] [Full Text] [Related]

  • 6. Synergistic inhibition of human immunodeficiency virus isolates (including 3'-azido-3'-deoxythymidine-resistant isolates) by foscarnet in combination with 2',3'-dideoxyinosine or 2',3'-dideoxycytidine.
    Palmer S, Harmenberg J, Cox S.
    Antimicrob Agents Chemother; 1996 May 21; 40(5):1285-8. PubMed ID: 8723486
    [Abstract] [Full Text] [Related]

  • 7. Mutants of feline immunodeficiency virus resistant to 3'-azido-3'-deoxythymidine.
    Remington KM, Chesebro B, Wehrly K, Pedersen NC, North TW.
    J Virol; 1991 Jan 21; 65(1):308-12. PubMed ID: 1845891
    [Abstract] [Full Text] [Related]

  • 8. Study of human immunodeficiency virus resistance to 2'-3'-dideoxyinosine and zidovudine in sequential isolates from pediatric patients on long-term therapy.
    Dimitrov DH, Hollinger FB, Baker CJ, Kline MW, Doyle M, Bremer JW, Shearer WT.
    J Infect Dis; 1993 Apr 21; 167(4):818-23. PubMed ID: 8450246
    [Abstract] [Full Text] [Related]

  • 9. Correlation of clinical progression in human immunodeficiency virus-infected children with in vitro zidovudine resistance measured by a direct quantitative peripheral blood lymphocyte assay.
    Nielsen K, Wei LS, Sim MS, Deveikis A, Keller M, Stiehm ER, Frenkel LM, Bryson YJ.
    J Infect Dis; 1995 Aug 21; 172(2):359-64. PubMed ID: 7622878
    [Abstract] [Full Text] [Related]

  • 10. Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects.
    Boucher CA, O'Sullivan E, Mulder JW, Ramautarsing C, Kellam P, Darby G, Lange JM, Goudsmit J, Larder BA.
    J Infect Dis; 1992 Jan 21; 165(1):105-10. PubMed ID: 1370174
    [Abstract] [Full Text] [Related]

  • 11. Long-term persistence of zidovudine resistance mutations in plasma isolates of human immunodeficiency virus type 1 of dideoxyinosine-treated patients removed from zidovudine therapy.
    Smith MS, Koerber KL, Pagano JS.
    J Infect Dis; 1994 Jan 21; 169(1):184-8. PubMed ID: 7506280
    [Abstract] [Full Text] [Related]

  • 12. Resistance to AZT and ddC during long-term combination therapy in patients with advanced infection with human immunodeficiency virus.
    Richman DD, Meng TC, Spector SA, Fischl MA, Resnick L, Lai S.
    J Acquir Immune Defic Syndr (1988); 1994 Feb 21; 7(2):135-8. PubMed ID: 7905522
    [Abstract] [Full Text] [Related]

  • 13. Zidovudine resistance, syncytium-inducing phenotype, and HIV disease progression in a case-control study. The VA Cooperative Study Group.
    St Clair MH, Hartigan PM, Andrews JC, Vavro CL, Simberkoff MS, Hamilton JD.
    J Acquir Immune Defic Syndr (1988); 1993 Aug 21; 6(8):891-7. PubMed ID: 8315574
    [Abstract] [Full Text] [Related]

  • 14. Zidovudine-resistant human immunodeficiency virus selected by passage in cell culture.
    Larder BA, Coates KE, Kemp SD.
    J Virol; 1991 Oct 21; 65(10):5232-6. PubMed ID: 1716689
    [Abstract] [Full Text] [Related]

  • 15. Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus.
    Richman DD, Grimes JM, Lagakos SW.
    J Acquir Immune Defic Syndr (1988); 1990 Oct 21; 3(8):743-6. PubMed ID: 2114476
    [Abstract] [Full Text] [Related]

  • 16. In-vitro resistance to zidovudine and alpha-interferon in HIV-1 isolates from patients: correlations with treatment duration and response.
    Edlin BR, St Clair MH, Pitha PM, Whaling SM, King DM, Bitran JD, Weinstein RA.
    Ann Intern Med; 1992 Sep 15; 117(6):457-60. PubMed ID: 1503348
    [Abstract] [Full Text] [Related]

  • 17. Administration of zidovudine for treatment of infection due to human immunodeficiency virus.
    Blott KW.
    Rev Infect Dis; 1991 Sep 15; 13(1):186-7. PubMed ID: 2017626
    [No Abstract] [Full Text] [Related]

  • 18. Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistance.
    Hammond JL, Koontz DL, Bazmi HZ, Beadle JR, Hostetler SE, Kini GD, Aldern KA, Richman DD, Hostetler KY, Mellors JW.
    Antimicrob Agents Chemother; 2001 Jun 15; 45(6):1621-8. PubMed ID: 11353603
    [Abstract] [Full Text] [Related]

  • 19. Decreased in vitro susceptibility to zidovudine of HIV isolates obtained from patients with AIDS.
    Land S, Terloar G, McPhee D, Birch C, Doherty R, Cooper D, Gust I.
    J Infect Dis; 1990 Feb 15; 161(2):326-9. PubMed ID: 2299212
    [Abstract] [Full Text] [Related]

  • 20. Long-term foscarnet therapy not associated with the development of foscarnet-resistant human immunodeficiency virus type 1 in an acquired immunodeficiency syndrome patient.
    Tachedjian G, Hoy J, McGavin K, Birch C.
    J Med Virol; 1994 Feb 15; 42(2):207-11. PubMed ID: 7512615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.